about
Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical ModelAnti-tax interacting protein-1 (TIP-1) monoclonal antibody targets human cancers.Radiolabeling strategies for tumor-targeting proteinaceous drugs.Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.Continued rapid growth in (68) Ga applications: update 2013 to June 2014.Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry.Microbial transglutaminase and c-myc-tag: a strong couple for the functionalization of antibody-like protein scaffolds from discovery platforms.Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2×Anti-HSG Bispecific Antibody and a (177)Lu-Labeled Peptide.New insights into the pretargeting approach to image and treat tumours.Prospective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation.In vivo demonstration of an active tumor pretargeting approach with peptide nucleic acid bioconjugates as complementary system.Sensitivity of pretargeted immunoPET using 68Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with 18FDG PET-CT.Adamantane/Cucurbituril: A Potential Pretargeted Imaging Strategy in Immuno-PETTheranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma
P2860
Q36245624-A87FBFA3-EBB3-4667-8F87-5339C1439499Q37536570-5ABAA888-D1FA-4B8E-B3E7-09E18D04FE53Q38189541-F63BCB3C-5B7E-4B1D-BD07-20DC85CD012FQ38230884-73B817F4-FAC5-444D-B427-B81F74C226B0Q38358666-1EFE58FB-51B6-4C0B-A07A-1D21B8B78628Q38722557-979D88E2-1092-4272-9AC1-5FD21D655280Q38908797-0BBFA3BF-6B5D-4A24-9996-FAE2116C18F0Q38956099-CFADB3A4-CA8A-4E27-9464-16D9882E9930Q38976879-DF153D6E-30AE-4BA3-A117-4E55DFDF3037Q54257268-10F39C88-27FB-46E4-9790-BEC7A4F8C007Q55093431-67E6D5AB-06F4-40B6-8527-A1A8EBD63FBDQ55286801-EF81308B-7CC4-4686-96E8-873F3AE0D98CQ57826559-1752AF71-1B2E-4D89-B92C-3CDD65DEC28BQ59133661-51D5C7C6-146D-4AA3-81CE-E43E54FDE444
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Improvement of radioimmunotherapy using pretargeting.
@en
type
label
Improvement of radioimmunotherapy using pretargeting.
@en
prefLabel
Improvement of radioimmunotherapy using pretargeting.
@en
P2093
P2860
P356
P1476
Improvement of radioimmunotherapy using pretargeting.
@en
P2093
Caroline Rousseau
Eric Frampas
Jacques Barbet
Jean-Francois Chatal
P2860
P356
10.3389/FONC.2013.00159
P577
2013-06-20T00:00:00Z